Zoli Mikoczy

40 papers receiving 2.0k citations

Peers

Zoli Mikoczy
Comparison fields: 5 of 128
  • Endocrinology, Diabetes and Metabolism 609
  • Health, Toxicology and Mutagenesis 419
  • Public Health, Environmental and Occupational Health 355
  • Cancer Research 354
  • Molecular Biology 302
Replace Valerio Ramazzotti with:
Valerio Ramazzotti Italy
Jon P. Fryzek United States
R K Winkelmann United States
A Ciaccia Italy
Barbara S. Ducatman United States
Sara Maio Italy
Hong Sun United States
Brian C.‐H. Chiu United States
Lucia Miligi Italy
D. Michal Freedman United States
Zoli Mikoczy relative to Valerio Ramazzotti Italy Valerio Ramazzotti's profile →
Citations per field
00.5×6.0×
Valerio Ramazzotti · 1×
Citations per year

Countries citing papers authored by Zoli Mikoczy

Since Specialization
Citations

This map shows the geographic impact of Zoli Mikoczy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoli Mikoczy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoli Mikoczy more than expected).

Fields of papers citing papers by Zoli Mikoczy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoli Mikoczy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoli Mikoczy. The network helps show where Zoli Mikoczy may publish in the future.

Co-authorship network of co-authors of Zoli Mikoczy

This figure shows the co-authorship network connecting the top 25 collaborators of Zoli Mikoczy. A scholar is included among the top collaborators of Zoli Mikoczy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoli Mikoczy. Zoli Mikoczy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 75
2 73
3 4
4 21
5 84
6 27
7 21
8 27
9 9
10 74
11 175
12 35
13 65
14 25
15 27
16 54
17 30
18 56
19 469
20 69

About Zoli Mikoczy

Zoli Mikoczy is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Hematology, having authored 41 papers that have together received 2.1k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (11 papers), Acute Lymphoblastic Leukemia research (6 papers) and Occupational and environmental lung diseases (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (609 citations), Chemical Health and Safety (24 citations) and Health, Toxicology and Mutagenesis (419 citations). Zoli Mikoczy has collaborated with scholars based in Sweden, Finland and Spain. Frequent co-authors include Lars Hagmar, Birgitta Bülow, Eva Marie Erfurth, Ulf Strömberg, Carl‐Henrik Nordström, María Albin, Håkan Tinnerberg, Lars Rylander, Jonas Björk and Hans Welinder. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Chemosphere and International Journal of Environmental Research and Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026